Cited by 252Drug Transport and Resistance MechanismsBarrier Structure and Function StudiesPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index.

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Open access

Qosa, Hisham, Miller, David S., Pasinelli, Piera, Trotti, Davide·2015·Brain Research

DOI 10.1016/j.brainres.2015.07.005PMC PMC4681613

Open this paper in CoChat — free account

Abstract

The strength of the blood-brain barrier (BBB) in providing protection to the central nervous system from exposure to circulating chemicals is maintained by tight junctions between endothelial cells and by a broad range of transporter proteins that regulate exchange between CNS and blood. The most important transporters that restrict the permeability of large number of toxins as well as therapeutic agents are the ABC transporters. Among them, P-gp, BCRP, MRP1 and MRP2 are the utmost studied. These efflux transporters are neuroprotective, limiting the brain entry of neurotoxins; however, they could also restrict the entry of many therapeutics and contribute to CNS pharmacoresistance. Characterization of several regulatory pathways that govern expression and activity of ABC efflux transporters in the endothelium of brain capillaries have led to an emerging consensus that these processes are complex and contain several cellular and molecular elements. Alterations in ABC efflux transporters expression and/or activity occur in several neurological diseases. Here, we review the signaling pathways that regulate expression and transport activity of P-gp, BCRP, MRP1 and MRP2 as well as how their expression/activity changes in neurological diseases. This article is part of a Special Issue entitled SI: Neuroprotection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2015.07.005

Cites

214 of 214 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Parkinson's disease
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276
Schizophrenia
van Os, J., & Kapur, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60995-8 · Cited by 1,971
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Multiple sclerosis--the plaque and its pathogenesis.
Frohman, E., Racke, M., & Raine, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,793
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
[NO TITLE AVAILABLE]
Battle, D. E. (2013) · CoDAS · doi:10.1590/s2317-17822013000200017 · Cited by 1,569
Air Pollution-Related Illness: Effects of Particles
Nel, A. E. (2005) · Science · doi:10.1126/science.1108752 · Cited by 1,566
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,407
Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
Ma, F. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_419-2 · Cited by 1,241
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
The neuropathogenesis of AIDS
González‐Scarano, F., & Martín‐García, J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1527 · Cited by 1,093
Alzheimer's disease: strategies for disease modification
Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,075
Reactive species mechanisms of cellular hypoxia-reoxygenation injury
Li, C., & Jackson, R. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00112.2001 · Cited by 1,058
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2007) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Blood–brain barrier structure and function and the challenges for CNS drug delivery
Abbott, N. J. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9608-0 · Cited by 951
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1728 · Cited by 920
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.86 · Cited by 873
Human ATP-binding cassette (ABC) transporter family
Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-281 · Cited by 779
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases
Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 724
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J., & Rivest, S. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn752 · Cited by 710
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
Mao, Q., & Unadkat, J. D. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9668-6 · Cited by 708
Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1
Siddiqui, A. T. S., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A. C., Goldstein, D. B., Wood, N. W., & Sisodiya, S. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021986 · Cited by 668
The blood-brain barrier: an engineering perspective
Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662
P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model
Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660
Modelling of the blood–brain barrier in drug discovery and development
Cecchelli, R., Bérézowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M., & Fénart, L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2368 · Cited by 660
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y. H., & Yu, A. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 653
Emerging Concepts in the Immunopathogenesis of AIDS
Douek, D. C., Roederer, M., & Koup, R. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123549 · Cited by 633
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 631
The MRP family of drug efflux pumps
Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 615
Brain Inflammation and Alzheimer's-Like Pathology in Individuals Exposed to Severe Air Pollution
Calderón‐Garcidueñas, L., Reed, W., Maronpot, R. R., Henríquez-Roldán, C. F., Delgado‐Chávez, R., Calderón‐Garcidueñas, A. L., Valdez, I. Y. D., Franco-Lira, M., Aragón-Flores, M., Solt, A. C., et al. (2004) · Toxicologic Pathology · doi:10.1080/01926230490520232 · Cited by 602
ABC Transporters and the Blood-Brain Barrier
Begley, D. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 548
Choroid plexus epithelial expression of MDR 1 P glycoprotein and multidrug resistance-associated protein contribute to the blood–cerebrospinal-fluid drug-permeability barrier
Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., & Piwnica-Worms, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3900 · Cited by 531
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria
Kamiie, J., Ohtsuki, S., Iwase, R., Ohmine, K., Katsukura, Y., 矢内一成, Yumi, S., Uchida, Y., Ito, S., & Terasaki, T. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9532-4 · Cited by 494
Neurological Diseases in Relation to the Blood–Brain Barrier
Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 454
Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy
Miller, D. S., Bauer, B., & Hartz, A. M. S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07109 · Cited by 407
Self-citation
Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain
Nies, A. T., Jedlitschky, G., König, J., Herold‐Mende, C. C., Steiner, H. H., Schmitt, H.-P., & KEPPLER, D. O. R. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 399
Toll-Like Receptor 4 on Nonhematopoietic Cells Sustains CNS Inflammation during Endotoxemia, Independent of Systemic Cytokines
Chakravarty, S., & Herkenham, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4268-04.2005 · Cited by 396
Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase
Block, M. L., Wu, X., Pei, Z., Li, G., Wang, T., Qin, L., Wilson, B. C., Yang, J. H., Hong, J., & Veronesi, B. (2004) · The FASEB Journal · doi:10.1096/fj.04-1945fje · Cited by 379
Air Pollution and Hospital Admissions for Ischemic and Hemorrhagic Stroke Among Medicare Beneficiaries
Wellenius, G. A., Schwartz, J. D., & Mittleman, M. A. (2005) · Stroke · doi:10.1161/01.str.0000189687.78760.47 · Cited by 362
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier
Dauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas‐Duport, C., Couraud, P., Scherrmann, J., de Waziers, I., & Declèves, X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05720.x · Cited by 361
Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier
Miller, D. S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.03.003 · Cited by 359
Self-citation
Deposition of Alzheimer's ??-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
Vogelgesang, S., Cascorbi, I., Schroeder, E., Pahnke, J., Kroemer, H. K., Siegmund, W., Kunert‐Keil, C., Walker, L. C., & Warzok, R. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00005 · Cited by 357
Response: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
Fisher, R. S., Boas, W. V. E., Blume, W. T., Elger, C. E., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_4.x · Cited by 349
Molecular insights on the cerebral innate immune system
Rivest, S. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00055-7 · Cited by 338
Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer’s Disease
Hartz, A. M. S., Miller, D. S., & Bauer, B. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061754 · Cited by 329
Self-citation
Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
Zhou, S.-F., Wang, L.-L., Di, Y., Xue, C., Duan, W., Li, C., & Li, Y. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132870 · Cited by 318
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
van Assema, D. M. E., Lubberink, M., Bauer, M., van der Flier, W. M., Schuit, R. C., Windhorst, A. D., Comans, E. F. I., Hoetjes, N. J., Tolboom, N., Langer, O., et al. (2012) · Brain · doi:10.1093/brain/awr298 · Cited by 318
Several major antiepileptic drugs are substrates for human P-glycoprotein
Luna‐Tortós, C., Fedrowitz, M., & Löscher, W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.032 · Cited by 310
Nuclear Receptor Minireview Series
Olefsky, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100047200 · Cited by 309
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 295
Self-citation
Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy
Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., Rozemuller, A. J. M., van Horssen, J., & de Vries, H. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3895 · Cited by 293
Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators
Driessen, E., & Hollon, S. D. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.005 · Cited by 291
Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood–brain barrier
Nadeau, S., & Rivest, S. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00225-0 · Cited by 279
Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
Agarwal, S., Hartz, A. M. S., Elmquist, W. F., & Bauer, B. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440186 · Cited by 275
Tumor Necrosis Factor α and Endothelin-1 Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain Barrier
Bauer, B., Hartz, A. M. S., & Miller, D. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029512 · Cited by 275
Self-citation
Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 Signaling
Bauer, B., Hartz, A. M. S., Pekcec, A., Toellner, K., Miller, D. S., & Potschka, H. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041210 · Cited by 270
Self-citation
Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P‐glycoprotein up‐regulation at the blood‐brain barrier
Hartz, A. M. S., Bauer, B., Block, M. L., Hong, J., & Miller, D. S. (2008) · The FASEB Journal · doi:10.1096/fj.08-106997 · Cited by 269
Self-citation
Drug Resistance in Glioblastoma: A Mini Review
Haar, C. P., Hebbar, P., Wallace, G., Das, A., Vandergrift, W. A., Smith, J. A., Giglio, P., Patel, S. J., Ray, S. K., & Banik, N. L. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0701-1 · Cited by 269
Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux
Agarwal, S., Sane, R., Gallardo, J. L., Ohlfest, J. R., & Elmquist, W. F. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167601 · Cited by 269
Olive-Oil-Derived Oleocanthal Enhances β-Amyloid Clearance as a Potential Neuroprotective Mechanism against Alzheimer’s Disease: In Vitro and in Vivo Studies
Abuznait, A. H., Qosa, H., Busnena, B. A., Sayed, K. A. E., & Kaddoumi, A. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400024q · Cited by 266
Self-citation
Rat brain vascular distribution of interleukin‐1 type‐1 receptor immunoreactivity: Relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli
Konsman, J. P., Vigues, S., Mackerlova, L., Bristow, A., & Blomqvist, A. G. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20052 · Cited by 259
ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy
Lazarowski, A., Czornyj, L. A., Lubieniecki, F. J., Girardi, E., Vázquez, S., & D’Giano, C. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01302.x · Cited by 240
Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood–brain barrier
Eisenblaetter, T., Hüwel, S., & Galla, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02401-6 · Cited by 233
MDR1‐P‐Glycoprotein (ABCB1) Mediates Transport of Alzheimer’s Amyloid‐β Peptides—Implications for the Mechanisms of Aβ Clearance at the Blood–Brain Barrier
Kuhnke, D., Jedlitschky, G., Grube, M., Krohn, M., Jucker, M., Mosyagin, I., Cascorbi, I., Walker, L. C., Kroemer, H. K., Warzok, R., et al. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00075.x · Cited by 232
The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy
Brandt, C., Bethmann, K., Gastens, A. M., & Löscher, W. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.014 · Cited by 222
ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ 1–40 Peptides
Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D. G., Lue, L., Stanimirovic, D. B., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-08.2009 · Cited by 214
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy
Tan, N. C., Heron, S. E., Scheffer, I. E., Pelekanos, J. T., McMahon, J. M., Vears, D. F., Mulley, J. C., & Berkovic, S. F. (2004) · Neurology · doi:10.1212/01.wnl.0000137051.33486.c7 · Cited by 211
A primer on the mechanics of P-glycoprotein the multidrug transporter
Hennessy, M., & Spiers, P. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.10.007 · Cited by 208
Inhibition of the Multidrug Transporter P‐Glycoprotein Improves Seizure Control in Phenytoin‐treated Chronic Epileptic Rats
van Vliet, E. A., van Schaik, R., Edelbroek, P. M., Redeker, S., Aronica, E., Wadman, W. J., Marchi, N., Vezzani, A., & Gorter, J. A. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00496.x · Cited by 208
ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS
Daood, M. J., Tsai, C., Ahdab-Barmada, M., & Watchko, J. F. (2008) · Neuropediatrics · doi:10.1055/s-0028-1103272 · Cited by 208
The rat blood-brain barrier transcriptome
Enerson, B. E., & Drewes, L. R. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600249 · Cited by 205
Expression and functional characterization of ABCG2 in brain endothelial cells and vessels
Zhang, W., Mojsilovic‐Petrovic, J., Andrade, M. F., Zhang, H., Ball, M., & Stanimirovic, D. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1131fje · Cited by 204
Rapid Modulation of P-Glycoprotein-Mediated Transport at the Blood-Brain Barrier by Tumor Necrosis Factor-α and Lipopolysaccharide
Hartz, A. M. S., Bauer, B., Fricker, G., & Miller, D. S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017954 · Cited by 203
Self-citation
Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors
Aronica, E., Gorter, J. A., Jansen, G. H., Veelen, C. W. M. V., van Rijen, P. C., Leenstra, S., Ramkema, M., Scheffer, G. L., Scheper, R. J., & Troost, D. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00992-2 · Cited by 197
Localization of Breast Cancer Resistance Protein (BCRP) in Microvessel Endothelium of Human Control and Epileptic Brain
Aronica, E., Gorter, J. A., Redeker, S., van Vliet, E. A., Ramkema, M., Scheffer, G. L., Scheper, R. J., van der Valk, P., Leenstra, S., Baayen, J. C., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.66604.x · Cited by 194
Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment
Sills, G. J., Mohanraj, R., Butler, E., McCrindle, S., Collier, L., Wilson, E. A., & Brodie, M. J. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.46304.x · Cited by 192
In Vivo Activation of Human Pregnane X Receptor Tightens the Blood-Brain Barrier to Methadone through P-Glycoprotein Up-Regulation
Bauer, B., Yang, X., Hartz, A. M. S., Olson, E. R., Zhao, R., Kalvass, J. C., Pollack, G. M., & Miller, D. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023796 · Cited by 192
Self-citation
Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier
Poller, B., Drewe, J., Krähenbühl, S., Huwyler, J., & Gutmann, H. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9431-1 · Cited by 184
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice
Krohn, M., Lange, C., Hofrichter, J., Scheffler, K., Stenzel, J., Steffen, J., Schumacher, T., Brüning, T., Plath, A.-S., Alfen, F., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57867 · Cited by 183
Association of High-Level MRP1 Expression With Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma
Haber, M., Smith, J. L., Bordow, S. B., Flemming, C. L., Cohn, S. L., London, W. B., Marshall, G. M., & Norris, M. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6196 · Cited by 180
Enhanced Brain Amyloid-β Clearance by Rifampicin and Caffeine as a Possible Protective Mechanism Against Alzheimer's Disease
Qosa, H., Abuznait, A. H., Hill, R. A., & Kaddoumi, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120319 · Cited by 167
Self-citation
Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers
Wang, X., Campos, C. R., Peart, J. C., Smith, L. K., Boni, J. L., Cannon, R. E., & Miller, D. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2935-13.2014 · Cited by 164
Self-citation
Rapid Regulation of P-Glycoprotein at the Blood-Brain Barrier by Endothelin-1
Hartz, A. M. S., Bauer, B., Fricker, G., & Miller, D. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001503 · Cited by 161
Self-citation
Development of the blood‐brain barrier: A historical point of view
Ribatti, D., Nico, B., Enrico Crivellato, B., & Artico, M. (2006) · The Anatomical Record Part B The New Anatomist · doi:10.1002/ar.b.20087 · Cited by 157
Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier
Narang, V. S., Fraga, C. H., Kumar, N., Shen, J., Throm, S. L., Stewart, C. F., & Waters, C. M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00491.2007 · Cited by 157
Blood-CNS Barrier Impairment in ALS patients versus an animal model
Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 152
Expression of drug transporters at the blood–brain barrier using an optimized isolated rat brain microvessel strategy
Yousif, S., Cynthia Marie-claire, A., Roux, F. S., Scherrmann, J., & Declèves, X. (2006) · Brain Research · doi:10.1016/j.brainres.2006.11.089 · Cited by 149
Differences in amyloid-β clearance across mouse and human blood–brain barrier models: Kinetic analysis and mechanistic modeling
Qosa, H., Abuasal, B. S., Romero, I. A., Weksler, B., Couraud, P.-O., Keller, J. N., & Kaddoumi, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.023 · Cited by 146
Self-citation
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain
Cannon, R. E., Peart, J. C., Hawkins, B. T., Campos, C. R., & Miller, D. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203534109 · Cited by 146
Self-citation
HIV-1 Viral Envelope Glycoprotein gp120 Triggers an Inflammatory Response in Cultured Rat Astrocytes and Regulates the Functional Expression of P-Glycoprotein
Ronaldson, P. T., & Bendayan, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025973 · Cited by 145
Role of ABC Transporters in the Pathogenesis of Alzheimer’s Disease
Abuznait, A. H., & Kaddoumi, A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300077c · Cited by 145
ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
Lin, F., de Gooijer, M. C., Roig, E. M., Buil, L. C. M., Christner, S. M., Beumer, J. H., Würdinger, T., Beijnen, J. H., & van Tellingen, O. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0084 · Cited by 145
Differential expression of the multidrug resistance‐related proteins ABCb1 and ABCc1 between blood‐brain interfaces
Gazzin, S., Strazielle, N., Schmitt, C., Fèvre‐Montange, M., Ostrow, J. D., Tiribelli, C., & Ghersi‐Egea, J. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21808 · Cited by 144
COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats
van Vliet, E. A., Zibell, G., Pekcec, A., Schlichtiger, J., Edelbroek, P. M., Holtman, L., Aronica, E., Gorter, J. A., & Potschka, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.09.012 · Cited by 144
ABC efflux transporters in brain vasculature of Alzheimer's subjects
Wijesuriya, H. C., Bullock, J. Y., Faull, R. L. M., Hladky, S. B., & Barrand, M. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.034 · Cited by 141
Regulation of ABC transporters at the blood–brain barrier
Miller, D. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.64 · Cited by 139
Self-citation
Multidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier
Régina, A., Demeule, M., Laplante, A., Jodoin, J., Dagenais, C., Berthelet, F., Moghrabi, A., & Béliveau, R. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013104423154 · Cited by 136
Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition
Zibell, G., Unkrüer, B., Pekcec, A., Hartz, A. M. S., Bauer, B., Miller, D. S., & Potschka, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.01.009 · Cited by 133
Self-citation
Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones
Hirrlinger, J., König, J., & Dringen, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01082.x · Cited by 132
Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood–brain barrier
Parrish, K., Sarkaria, J. N., & Elmquist, W. F. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.71 · Cited by 131
Apical-to-Basolateral Transport of Amyloid-β Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein
Candela, P., Gosselet, F., Saint-Pol, J., Sevin, E., Boucau, M.-C., Boulanger, E., Cecchelli, R., & Fenart, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100462 · Cited by 128
Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier
Wang, X., Sykes, D. B., & Miller, D. S. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.063685 · Cited by 127
Self-citation
P‐glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress
Felix, R. A., & Barrand, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00660.x · Cited by 125
Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response.
Ledoux, S., Yang, R., Friedlander, G., & Laouari, D. (2003) · PubMed · Cited by 125
ABC Transporters in the CNS – An Inventory
Hartz, A. M. S., & Bauer, B. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164020 · Cited by 124
Nuclear Receptors: Overview and Classification
Novac, N., & Heinzel, T. (2004) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010042634541 · Cited by 124
ABCG2- and ABCG4-Mediated Efflux of Amyloid-β Peptide 1-40 at the Mouse Blood-Brain Barrier
Minh, T. N., Noël‐Hudson, M., Ribes, S., Besengez, C., Smirnova, M., Cisternino, S., Buyse, M., Calon, F., Chimini, G., Chacun, H., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112189 · Cited by 116
Aβ1–42 reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling
Park, R., Kook, S.-Y., Park, J.-C., & Mook‐Jung, I. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.258 · Cited by 116
Over-expression of Pglycoprotein in malformations of cortical development
Sisodiya, S. M., Heffernan, J. M., & Squier, M. V. (1999) · Neuroreport · doi:10.1097/00001756-199911080-00032 · Cited by 115
N-Linked Glycosylation of the Human ABC Transporter ABCG2 on Asparagine 596 Is Not Essential for Expression, Transport Activity, or Trafficking to the Plasma Membrane
Diop, N. K., & Hrycyna, C. A. (2005) · Biochemistry · doi:10.1021/bi0479858 · Cited by 114
MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.
Tóth, K., Vaughan, M. M., Peress, N. S., Slocum, H. K., & Rustum, Y. M. (1996) · PubMed Central · Cited by 114
Aryl hydrocarbon receptor‐mediated up‐regulation of ATP‐driven xenobiotic efflux transporters at the blood‐brain barrier
Wang, X., Hawkins, B. T., & Miller, D. S. (2010) · The FASEB Journal · doi:10.1096/fj.10-169227 · Cited by 113
Self-citation
Immunohistochemical Localization of P-glycoprotein in Rat Brain and Detection of Its Increased Expression by Seizures Are Sensitive to Fixation and Staining Variables
Volk, H. A., Potschka, H., & Löscher, W. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6451.2005 · Cited by 112
ABC Transporters and the Alzheimer’s Disease Enigma
Wolf, A. M., Bauer, B., & Hartz, A. M. S. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00054 · Cited by 109
Modulating P‐glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies?
Potschka, H. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02585.x · Cited by 108
P-Glycoprotein and Breast Cancer Resistance Protein Restrict Apical-to-Basolateral Permeability of Human Brain Endothelium to Amyloid-β
Tai, L. M., Loughlin, A. J., Male, D. K., & Romero, I. A. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.42 · Cited by 108
Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line
Zastre, J. A., Chan, G. N. Y., Ronaldson, P. T., Ramaswamy, M., Couraud, P. O., Romero, I. A., Weksler, B. B., Bendayan, M., & Bendayan, R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21898 · Cited by 108
P‐glycoprotein in blood–brain barrier endothelial cells: interaction and oligomerization with caveolins
Jodoin, J., Demeule, M., Fénart, L., Cecchelli, R., Farmer, S., Linton, K. J., Higgins, C. F., & Béliveau, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02081.x · Cited by 108
Rapid, Reversible Modulation of Blood–Brain BarrierP-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor
Hawkins, B. T., Sykes, D. B., & Miller, D. S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-09.2010 · Cited by 107
Self-citation
Intracellular trafficking of P-glycoprotein
Fu, D., & Arias, I. M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.12.009 · Cited by 107
Regulation of major efflux transporters under inflammatory conditions at the blood‐brain barrierin vitro
von Wedel-Parlow, M., Wölte, P., & Galla, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06305.x · Cited by 106
Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism
Zhu, H., & Liu, G.-Q. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.02.027 · Cited by 105
HIV‐1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein‐1 (Mrp1) in glial cells
Ronaldson, P. T., & Bendayan, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05479.x · Cited by 100
Targeting Prostaglandin E2 EP1 Receptors Prevents Seizure-Associated P-glycoprotein Up-Regulation
Pekcec, A., Unkrüer, B., Schlichtiger, J., Soerensen, J., Hartz, A. M. S., Bauer, B., van Vliet, E. A., Gorter, J. A., & Potschka, H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152520 · Cited by 97
Evolution of ABC transporters by gene duplication and their role in human disease
Moitra, K., & Dean, M. C. (2011) · Biological Chemistry · doi:10.1515/bc.2011.006 · Cited by 96
Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
Jablonski, M., Markandaiah, S. S., Jacob, D. A., Meng, N. J., Li, K., Gennaro, V. J., Lepore, A. C., Trotti, D., & Pasinelli, P. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.141 · Cited by 94
Self-citation
Amyotrophic lateral sclerosis: update and new developments
Perry, J. J. P., Pratt, A. J., & Getzoff (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19803 · Cited by 94
HIV-TAT Protein Upregulates Expression of Multidrug Resistance Protein 1 in the Blood–Brain Barrier
Hayashi, K., Pu, H., Andras, I. E., Eum, S. Y., Yamauchi, A., Hennig, B., & Toborek, M. J. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600254 · Cited by 94
17-β-Estradiol: A Powerful Modulator of Blood–Brain Barrier BCRP Activity
Hartz, A. M. S., Mahringer, A., Miller, D. S., & Bauer, B. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.36 · Cited by 94
Self-citation
Selective increase of two ABC drug efflux transporters at the blood–spinal cord barrier suggests induced pharmacoresistance in ALS
Jablonski, M., Jacob, D. A., Campos, C. R., Miller, D. S., Maragakis, N. J., Pasinelli, P., & Trotti, D. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.040 · Cited by 91
Self-citation
Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis
Kooij, G., Mizee, M. R., van Horssen, J., Reijerkerk, A., Witte, M. E., Drexhage, J. A. R., van der Pol, S. M. A., van het Hof, B., Scheffer, G., Scheper, R., et al. (2011) · Brain · doi:10.1093/brain/awq330 · Cited by 90
Cellular localization and functional expression of P‐glycoprotein in rat astrocyte cultures
Ronaldson, P. T., Bendayan, M., Gingras, D., Piquette‐Miller, M., & Bendayan, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02417.x · Cited by 89
Pharmacology and Physiopathology of the Brain Endothelin System: An Overview
Schinelli, S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776055652 · Cited by 87
Functional Expression of the Multidrug Resistance Protein 1 in Microglia
Dallas, S., Zhu, X., Baruchel, S., Schlichter, L. C., & Bendayan, R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054304 · Cited by 87
Cerebral expression of drug transporters in epilepsy
Aronica, E., Sisodiya, S. M., & Gorter, J. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.008 · Cited by 86
Molecular and functional MDR1‐Pgp and MRPs expression in human glioblastoma multiforme cell lines
Declèves, X., Fajac, A., Lehmann‐Che, J., Tardy, M., Mercier, C., Hurbain, I., Laplanche, J., Bernaudin, J., & Scherrmann, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10135 · Cited by 86
Modulation of p‐glycoprotein function by caveolin‐1 phosphorylation
Barakat, S., Demeule, M., Pilorget, A., Régina, A., Gingras, D., Baggetto, L. G., & Béliveau, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04410.x · Cited by 85
A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1
Chang, X.-B. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9041-7 · Cited by 83
Minocycline and riluzole brain disposition: interactions with p‐glycoprotein at the blood–brain barrier
Milane, A., Fernandez, C., Vautier, S., Bensimon, G., Meininger, V., & Farinotti, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04772.x · Cited by 83
MDR1 variants and risk of Parkinson disease
Zschiedrich, K., König, I. R., Brüggemann, N., Kock, N., Kasten, M., Leenders, K. L., Kostić, V., Vieregge, P., Ziegler, A., Klein, C., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0089-x · Cited by 80
Pro-Inflammatory Cytokine Regulation of P-glycoprotein in the Developing Blood-Brain Barrier
Iqbal, M., Ho, H. L., Sophie Petropoulos, A., Moisiadis, V. G., Gibb, W., & Matthews, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043022 · Cited by 79
St.John'sWort Reduces Beta‐Amyloid Accumulation in a Double TransgenicAlzheimer's Disease Mouse Model—Role of P‐Glycoprotein
Brenn, A., Grube, M., Jedlitschky, G., Fischer, A., Strohmeier, B., Eiden, M., Keller, M., Groschup, M. H., & Vogelgesang, S. (2014) · Brain Pathology · doi:10.1111/bpa.12069 · Cited by 79
HIV‐Tat protein induces P‐glycoprotein expression in brain microvascular endothelial cells
Hayashi, K., Pu, H., Tian, J., Andras, I. E., Lee, Y. W., Hennig, B., & Toborek, M. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03114.x · Cited by 78
Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy
Kim, D. W., Lee, S. K., Chu, K., Jang, I., Yu, K., Cho, J., & Kim, S.-J. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.12.001 · Cited by 77
Expression of ATP-Binding Cassette Membrane Transporters in Rodent and Human Sertoli Cells: Relevance to the Permeability of Antiretroviral Therapy at the Blood-Testis Barrier
Robillard, K. R., Hoque, T., & Bendayan, R. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.186916 · Cited by 76
Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood–brain barrier
de Klerk, O. L., Willemsen, A. T. M., Roosink, M., Bartels, A. L., Hendrikse, N. H., Bosker, F. J., & den Boer, J. A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009894 · Cited by 75
Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia:
de Klerk, O. L., Willemsen, A. T. M., Bosker, F. J., Bartels, A. L., Hendrikse, N. H., den Boer, J. A., & Dierckx, R. A. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.05.002 · Cited by 74
Targeting regulation of ABC efflux transporters in brain diseases: A novel therapeutic approach
Potschka, H. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.004 · Cited by 71
T lymphocytes impair P-glycoprotein function during neuroinflammation
Kooij, G., van Horssen, J., de Lange, E. C. M., Reijerkerk, A., van der Pol, S. M. A., Hof, B. V. H., Drexhage, J., Vennegoor, A., Killestein, J., Scheffer, G. L., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.10.006 · Cited by 70
Estrogen Receptor β Signaling through Phosphatase and Tensin Homolog/Phosphoinositide 3-Kinase/Akt/Glycogen Synthase Kinase 3 Down-Regulates Blood-Brain Barrier Breast Cancer Resistance Protein
Hartz, A. M. S., Madole, E. K., Miller, D. S., & Bauer, B. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168930 · Cited by 70
Self-citation
The multidrug-resistance gene MDR1 is expressed in human glial tumors
Becker, I., Becker, K., Meyermann, R., & H�llt, V. (1991) · Acta Neuropathologica · doi:10.1007/bf00293387 · Cited by 68
Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro
Zembruski, N. C. L., Büchel, G., Jodicke, L., Herzog, M., Haefeli, W. E., & Weiss, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq501 · Cited by 67
Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats
Dazert, P., Suofu, Y., Grube, M., Popa‐Wagner, A., Kroemer, H. K., Jedlitschky, G., & Kessler, C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.056 · Cited by 66
Placental ABC transporters, cellular toxicity and stress in pregnancy
Aye, I. L. M. H., & Keelan, J. A. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.03.007 · Cited by 66
Expression of the ATP-binding Cassette Membrane Transporter, ABCG2, in Human and Rodent Brain Microvessel Endothelial and Glial Cell Culture Systems
Lee, G. S., Babakhanian, K., Ramaswamy, M., Prat, A., Wosik, K., & Bendayan, R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9244-1 · Cited by 66
ABCC1: a gateway for pharmacological compounds to the ischaemic brain
Kılıç, E., Spudich, A., Kılıç, Ü., Rentsch, K., Vig, R., Matter, C. M., Wunderli‐Allenspach, H., Fritschy, J., Bassetti, C. L., & Hermann, D. M. (2008) · Brain · doi:10.1093/brain/awn222 · Cited by 65
Signalling pathways influencing basal and H2O2‐induced P‐glycoprotein expression in endothelial cells derived from the blood–brain barrier
Nwaozuzu, O. M., Sellers, L. A., & Barrand, M. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02061.x · Cited by 64
Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood–brain barrier model
Qosa, H., LeVine, H., Keller, J. N., & Kaddoumi, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.029 · Cited by 64
Self-citation
Role of drug efflux carriers in the healthy and diseased brain
Hermann, D. M., Kılıç, E., Spudich, A., Krämer, S. D., Wunderli‐Allenspach, H., & Bassetti, C. L. (2006) · Annals of Neurology · doi:10.1002/ana.21012 · Cited by 64
Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells.
Kania, K., Wijesuriya, H. C., Hladky, S., & Barrand, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.044 · Cited by 63
Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat
Gazzin, S., Berengeno, A. L., Strazielle, N., Fazzari, F. G. T., Raseni, A., Ostrow, J. D., Wennberg, R. P., Ghersi‐Egea, J., & Tiribelli, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016165 · Cited by 63
Alteration in P-glycoprotein at the blood–brain barrier in the early period of MCAO in rats
Cen, J., Liu, L., Ming-shan, L., He, L., Wang, L., Liu, Y., Liu, M., & Ji, B. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12033 · Cited by 60
Induction of P-Glycoprotein by Antiretroviral Drugs in Human Brain Microvessel Endothelial Cells
Chan, G. N. Y., Patel, R., Cummins, C. L., & Bendayan, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00486-13 · Cited by 59
Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures
Kotsopoulos, I. A. W., de Krom, M. C. T. F. M., Kessels, F., Lodder, J., Troost, J., Twellaar, M., Merode, T. V., & Knottnerus, J. A. (2005) · Seizure · doi:10.1016/j.seizure.2005.01.005 · Cited by 57
The Cross-Talk between Canonical and Non-Canonical Wnt-Dependent Pathways Regulates P-Glycoprotein Expression in Human Blood–Brain Barrier Cells
Pinzón‐Daza, M. L., Salaroglio, I. C., Kopecka, J., Garzón, R., Couraud, P., Ghigo, D., & Riganti, C. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.100 · Cited by 56
Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia
Ak, H., Ay, B., Tanrıverdi, T., Sanuş, G. Z., İş, M., Sar, M., Öz, B., Özkara, Ç., Özyurt, E., & Uzan, M. (2007) · Seizure · doi:10.1016/j.seizure.2007.03.011 · Cited by 55
Involvement of the Multidrug Resistance Protein 3 in Drug Sensitivity and Its Expression in Human Glioma
Haga, S., Hinoshita, E., Ikezaki, K., Fukui, M., Scheffer, G. L., Uchiumi, T., & Kuwano, M. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01084.x · Cited by 52
Activation of PKC Isoform β I at the Blood–Brain Barrier Rapidly Decreases P-Glycoprotein Activity and Enhances Drug Delivery to the Brain
Rigor, R. R., Hawkins, B. T., & Miller, D. S. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.21 · Cited by 52
Self-citation
Brain Metastases
Kamar, F. G., & Posner, J. B. (2010) · Seminars in Neurology · doi:10.1055/s-0030-1255225 · Cited by 52
Apolipoprotein E Controls ATP-Binding Cassette Transporters in the Ischemic Brain
ElAli, A., & Hermann, D. M. (2010) · Science Signaling · doi:10.1126/scisignal.2001213 · Cited by 49
BCRP at the Blood−Brain Barrier: Genomic Regulation by 17β-Estradiol
Mahringer, A., & Fricker, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001729 · Cited by 49
Modulation of P‐glycoprotein function by sphingosine kinase‐1 in brain endothelial cells
Pilorget, A., Demeule, M., Barakat, S., Marvaldi, J. L., Luis, J., & Béliveau, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04295.x · Cited by 49
Mrp1 is Essential for Sphingolipid Signaling to P-Glycoprotein in Mouse Blood–Brain and Blood–Spinal Cord Barriers
Cartwright, T. A., Campos, C. R., Cannon, R. E., & Miller, D. S. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.174 · Cited by 48
Self-citation
Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients
Westerlund, M., Belin, A. C., Olson, L., & Galter, D. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0686-5 · Cited by 45
Brain Distribution of Cediranib Is Limited by Active Efflux at the Blood-Brain Barrier
Wang, T., Agarwal, S., & Elmquist, W. F. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190488 · Cited by 44
Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt–Jakob disease
Vogelgesang, S., Glatzel, M., Walker, L. C., Kroemer, H. K., Aguzzi, A., & Warzok, R. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0042-3 · Cited by 43
Induction of P‐glycoprotein and Bcrp at the rat blood–brain barrier following a subchronic morphine treatment is mediated through NMDA / COX ‐2 activation
Yousif, S., Chaves, C., Potin, S., Margaill, I., Scherrmann, J., & Declèves, X. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07890.x · Cited by 43
The worldwide burden of stroke: current status and future projections.
Truelsen, T., & Bonita, R. (2009) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(08)01916-7 · Cited by 42
ABC Transporter Regulation by Signaling at the Blood–Brain Barrier
Miller, D. S. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.008 · Cited by 39
Self-citation
Amyotrophic lateral sclerosis: update and new developments
Pratt, A. J., Getzoff, E. D., & P Perry, J. J. (2012) · Dove Medical Press (Taylor and Francis Group) · Cited by 39
Regulation of P‐glycoprotein by human immunodeficiency virus‐1 in primary cultures of human fetal astrocytes
Ashraf, T., Ronaldson, P. T., Persidsky, Y., & Bendayan, R. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22720 · Cited by 39
P-gp Transporter and its Role in Neurodegenerative Diseases
Rapposelli, S., Digiacomo, M., & Balsamo, A. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521544 · Cited by 37
P‐glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia–reoxygenation
Robertson, S. J., Kania, K., Hladky, S. B., & Barrand, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06306.x · Cited by 37
Ionotropic Glutamate Receptor Biology: Effect on Synaptic Connectivity and Function in Neurological Disease
Barnes, G. N., & Slevin, J. T. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456800 · Cited by 36
The ABC of glycosylation
Perego, P., Gatti, L., & Beretta, G. L. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2789-c1 · Cited by 33
ABC Transporter Function and Regulation at the Blood–Spinal Cord Barrier
Campos, C. R., Schröter, C., Wang, X., & Miller, D. S. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.47 · Cited by 31
Self-citation
Rapid Loss of Blood–Brain Barrier P-Glycoprotein Activity through Transporter Internalization Demonstrated Using a Novel in Situ Proteolysis Protection Assay
Hawkins, B. T., Rigor, R. R., & Miller, D. S. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.117 · Cited by 30
Self-citation

Flagged first, then by citations

1 of the 215 references couldn’t be matched to a known paper.

Sorted by citations

Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 398
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P. K., & Abbott, N. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 311
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders
Correia, A. D. A., Monteiro, A. R., Silva, R., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114485 · Cited by 219

See all 252

Authors: Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D.
Affiliations: Thomas Jefferson University (US)
National Institutes of Health (US)
Corresponding author: Qosa, Hisham
Trotti, Davide
ORCID: Qosa, Hisham
Pasinelli, Piera
Trotti, Davide
Venue: Brain Research
Publisher: Elsevier BV
Published: 2015-12
Volume: 1628
Issue: Pt B
Pages: 298-316
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/j.brainres.2015.07.005
PMC: PMC4681613
OpenAlex: W908901015
Cited by: 249
References: 215
Citations by year: 2026: 17 · 2025: 15 · 2024: 19 · 2023: 27 · 2022: 26 · 2021: 30 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 18 · 2016: 23 · 2015: 1
FWCI: 2.29
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Health (RO1-NS074886)
Intramural Research program NIH/NIEHS
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords: ABC transporters, blood-brain barrier, P-glycoprotein, ABCG2, MRP1, MRP2, efflux pumps, transporter regulation, tight junctions, neurological disorders, neuroprotection, signaling pathways, brain capillary endothelium
MeSH terms: Animals, Blood-Brain Barrier, Humans, Nervous System Diseases, ATP-Binding Cassette Transporters

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks